Consistent with my revised thesis and the elevated regulatory risk, I’ve outlined a downside range on the chart where I’d consider getting involved. The top of the zone is marked at $2.51 (April low), with the lower boundary at $1.81, the October 2023 low.
Given the current backdrop, I’m not stepping in until price moves into this range and the broader setup improves. I’m leaning more toward the lower end, particularly around the $2.00 area or below, as a potential entry, but only if conditions warrant it.
No need to force anything here. Staying patient and letting price come to me.
Given the current backdrop, I’m not stepping in until price moves into this range and the broader setup improves. I’m leaning more toward the lower end, particularly around the $2.00 area or below, as a potential entry, but only if conditions warrant it.
No need to force anything here. Staying patient and letting price come to me.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。